Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders

ABSTRACT Background: Azathioprine is a common first-line therapy for neuromyelitis optica spectrum disorder (NMOSD). Objective: The aim of this study was to determine whether long-term treatment (>10 years) with azathioprine is safe in NMOSD. Methods: We conducted a retrospective medical record...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ana Beatriz Ayroza Galvão Ribeiro GOMES, Milena Sales PITOMBEIRA, Douglas Kazutoshi SATO, Dagoberto CALLEGARO, Samira Luisa APÓSTOLOS-PEREIRA
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Thieme Revinter Publicações 2021-03-01
Σειρά:	Arquivos de Neuro-Psiquiatria
Θέματα:	Azathioprine Neuromyelitis Optica Therapeutics
Διαθέσιμο Online:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000300229&tlng=en
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!